scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.YMETH.2014.12.017 |
P698 | PubMed publication ID | 25562748 |
P50 | author | Fernando A. Soares | Q43653328 |
Jose Vassallo | Q45738317 | ||
P2093 | author name string | I W Cunha | |
R M Rocha | |||
A M Lavorato-Rocha | |||
L G Anjos | |||
P2860 | cites work | The lipid phosphatase activity of PTEN is critical for its tumor supressor function | Q22007981 |
P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase | Q24322705 | ||
Protean PTEN: form and function | Q24613810 | ||
FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome. | Q27851411 | ||
Evaluation of reliability of FISH versus brightfield dual-probe in situ hybridization (BDISH) for frontline assessment of HER2 status in breast cancer samples in a community setting: influence of poor tissue preservation | Q34415475 | ||
Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast | Q35788322 | ||
Quantification of immunohistochemistry--issues concerning methods, utility and semiquantitative assessment I. | Q36595208 | ||
PTEN: a new guardian of the genome. | Q37270432 | ||
Computer-aided techniques for chromogenic immunohistochemistry: status and directions | Q38043669 | ||
Molecular pathways: intercellular PTEN and the potential of PTEN restoration therapy | Q38264216 | ||
Immunohistochemical analysis of PTEN in endometrial carcinoma: a tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities | Q40485163 | ||
MGMT and PTEN as potential prognostic markers in breast cancer | Q42496377 | ||
Optimal protocol for PTEN immunostaining; role of analytical and preanalytical variables in PTEN staining in normal and neoplastic endometrial, breast, and prostatic tissues | Q44529091 | ||
Biotin-free systems provide stronger immunohistochemical signal in oestrogen receptor evaluation of breast cancer. | Q46008667 | ||
Best practice for PTEN gene and protein assessment in anatomic pathology | Q46825031 | ||
PIK3CA gene mutations in endometrial carcinoma: correlation with PTEN and K-RAS alterations. | Q54584081 | ||
Comparative analysis of six different antibodies against Her2 including the novel rabbit monoclonal antibody (SP3) and chromogenic in situ hybridisation in breast carcinomas | Q81261913 | ||
P921 | main subject | best practice | Q830382 |
immunohistochemistry | Q899285 | ||
vulvar cancer | Q1908194 | ||
P1104 | number of pages | 5 | |
P304 | page(s) | 20-24 | |
P577 | publication date | 2015-01-03 | |
P1433 | published in | Methods | Q6823859 |
P1476 | title | Immunohistochemical assessment of PTEN in vulvar cancer: best practices for tissue staining, evaluation, and clinical association | |
P478 | volume | 77-78 |
Q87056285 | A rapid guide to PTEN function |
Q54116348 | Aberrant Expression of Extracellular Signal-Regulated Kinase and 15-Hydroxyprostaglandin Dehydrogenase Indicates Radiation Resistance and Poor Prognosis for Patients with Clival Chordomas. |
Q42134201 | Chronic saponin treatment attenuates damage to the pancreas in chronic alcohol-treated diabetic rats |
Q48580128 | Differences in Dural Penetration of Clival Chordomas Are Associated with Different Prognosis and Expression of Platelet-Derived Growth Factor Receptor-β. |
Q35986673 | Inactivation of tumor suppressor gene pten in early and advanced gallbladder cancer |
Q64114534 | Precise definition of PTEN C-terminal epitopes and its implications in clinical oncology |
Q28384556 | Role and mechanism of miR-222 in arsenic-transformed cells for inducing tumor growth |
Q33648719 | S100A7 promotes the migration, invasion and metastasis of human cervical cancer cells through epithelial-mesenchymal transition |
Q38968517 | Using Digital Quantification of Stained Tissue Microarrays as a Medium-Throughput, Quantitative Method for Measuring the Kinetics of Signal Transduction |
Search more.